The Death of the Bedside Manner; ObamaCare is speeding the decline in the quality of medical practice.

Marc Siegel: The Death of the Bedside Manner

ObamaCare is speeding the decline in the quality of medical practice.

MARC SIEGEL

Dec. 26, 2013 7:17 p.m. ET

‘It is as painful perhaps to be awakened from a vision as to be born,” James Joyce wrote famously in his masterpiece “Ulysses.” I recently had such an experience when my office manager—who protects me from the daily insurance grind of referrals and approvals and pre-certifications and blood drawing—was out sick. Thus the veil was lifted from my eyes, and I awoke to the harsh realities of our medical future.One patient was severely depressed and needed medication and a referral to a psychiatrist. Another was having trouble breathing from asthma that requires inhalers. A third had a faded rash on her arm that she was ready to call a spider bite until she showed me a two-day-old iPhone photo. It was the angry red rash of Lyme disease. Each problem had an effective treatment but each visit took over half an hour to carefully complete.

The appointments were gratifying, in an old-fashioned way. Patients still have the expectation that their doctor will be patient and listen carefully, but one by one doctors and patients are awakening from that comforting vision of the past to the rushed, restricted world of the ObamaCare future. Thanks to that eye-opening week without my office manager, when I ran hours behind, I was forced to forfeit the vision I had of myself as an old country doctor practicing in a big city.

For me and many of my colleagues, the real practice of medicine is supposed to involve an intimate encounter with each patient and a diagnosis of illness leading to a potential cure. In the future, however, a diagnosis of Lyme disease or the severity of a patient’s depression may be missed because showing the photo or taking an extensive mental-health history doesn’t fit squarely into the 10-minute visit authorized by insurance, along with mandatory computer documentation, insurance verifications and appointment scheduling.

These problems predate ObamaCare, but the new law brings more regulations and low-quality insurance at a time when we are already struggling to comply with the electronic health-record mandate.

Supporters of health reform will say that theAffordable Care Act didn’t cause all these problems, that President Obama shouldn’t be blamed for wanting to make sure that everyone has health insurance. Unfortunately, the kind of insurance that is growing under ObamaCare’s fertilizer is the exact kind that was jeopardizing the quality of health care in the first place: the kind that pays for seeing a doctor when you are well, but where guidelines and regulations predominate and choice is restricted when you are seriously ill.

How can quality of care not be affected if the antibiotic or statin drug or MRI scan I feel you need isn’t covered under your plan? How can ObamaCare be labeled a success when it adds layers of bureaucracy to an already overburdened system?

This month, even as Health and Human Services struggles to fix the health-exchange websites, the Obama administration announced that errors are occurring on the back end between the government and insurers at a rate of one out of four enrollees. This means that when you come to see me in January, assuming I actually participate in your narrow new ObamaCare network, there is a substantial chance you will never make it past the front desk because your new insurance will not be active.

Since insurers are being compelled to cover more folks with pre-existing conditions, with no lifetime limits, and to cover everyone in a family plan at least up to the age of 26—all popular provisions of the ACA—they reduce costs by cutting fees to vulnerable doctors while restricting the tests they can order. This makes the practice of quality medicine almost impossible, but it helps preserve an insurance company’s bottom line while complying with a government mandate.

That copay that you no longer have to pay for colonoscopies or mammograms may have been the one bit of steady cash keeping in business many physicians and providers who perform them but work on very thin profit margins.

What should have been done? If the government felt that a significant segment of the population was underserved, they should have hired the doctors to serve them and built the clinics to serve them in—and mandated the scaled back, affordable insurance that covers severe illness only.

What ObamaCare gave us instead is a hybrid that should make both Democrats and Republicans, doctors and patients unhappy: big business combined with big government.

Dr. Siegel, a professor of medicine and medical director of Doctor Radio at New York University’s Langone Medical Center, is a Fox News medical correspondent.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment